• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Alcohol consumption inversely related to risk of developing Multiple Sclerosis

bys25qthea
January 7, 2014
in Chronic Disease, Neurology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Swedish adults who reported the highest amount of alcohol consumption had a decreased incidence of Multiple Sclerosis (MS).

Evidence grade: Level 3 (Average)

Study Rundown: MS is a chronic neurologic disease which is thought to have both environmental and genetic influences. Alcohol consumption is a modifiable environmental exposure which has, in other studies, been shown to have a protective factor against certain autoimmune diseases, such as autoimmune hypothyroidism, systemic lupus erythematosus, and rheumatoid arthritis. This study was designed to help determine whether a similar relationship exists between alcohol consumption and risk of developing MS. The results of the study demonstrated that participants with MS were less likely to be alcohol consumers compared to those without MS, who were more likely to be alcohol consumers.

Strengths include a large sample size of cases and controls that were randomly selected. The investigators also ensured that only properly filled out questionnaires were included in the final analysis. Weaknesses of the study include the fact that only Swedish people were included in the study. There was also a long list of environmental factors that were included in the questionnaire, which could have confounded the results.

Click to read the study in JAMA Neurology

RELATED REPORTS

Tolebrutinib not superior to teriflunomide in reducing relapsing multiple sclerosis relapse rates

Tolebrutinib reduces disability progression in nonrelapsing secondary progressive multiple sclerosis

#VisualAbstract: Tolebrutinib Reduced Disaibility Progression in Nonrelapsing Secondary Progressive Multiple Sclerosis

Relevant Reading: Caffeine and alcohol intakes have no association with risk of multiple sclerosis

In-Depth [case control study]: The study consisted of two case control studies from Sweden, Epidemiological Investigation of Multiple Sclerosis (EIMS) and Genes and Environment in Multiple Sclerosis (GEMS). While the questionnaires for the two studies were different, they both inquired about the participants’ alcohol consumption over a period of time. EIMS included 745 MS cases and 1761 controls, and GEMS included 5874 MS cases and 5246 controls.

In EIMS, women who reported high alcohol consumption had an OR of 0.6 (95% CI, 0.4-1.0) of developing MS compared to women who did not consume alcohol. Men with high alcohol consumption had an OR of 0.5 (95% CI, 0.2-1.0) compared to men who did not consume alcohol. In GEMS, the OR for women was 0.7 (95% CI, 0.6-0.9) and for men, it was 0.7 (95% CI, 0.5-0.9). Risk reduction was more pronounced in smokers than never smokers in the GEMS group (attributable proportion, 0.2; P=0.01).

By Anees Daud and James Jiang

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: Alcoholmultiple sclerosis
Previous Post

Mediterranean diet linked to reduced diabetes risk in high risk cardiovascular patients

Next Post

Transcutaneous bilirubinometry linked to decreased serum testing and costs [Pediatrics Classics Series]

RelatedReports

Chronic Disease

Tolebrutinib not superior to teriflunomide in reducing relapsing multiple sclerosis relapse rates

June 2, 2025
Asymptomatic women at high risk for Multiple Sclerosis may have early subclinical neuroimaging abnormalities
Chronic Disease

Tolebrutinib reduces disability progression in nonrelapsing secondary progressive multiple sclerosis

June 5, 2025
#VisualAbstract: Tolebrutinib Reduced Disaibility Progression in Nonrelapsing Secondary Progressive Multiple Sclerosis
StudyGraphics

#VisualAbstract: Tolebrutinib Reduced Disaibility Progression in Nonrelapsing Secondary Progressive Multiple Sclerosis

May 30, 2025
#VisualAbstract: Tolebrutinib is Not Superior to Teriflunomide in the Treatment of Relapsing Multiple Sclerosis
StudyGraphics

#VisualAbstract: Tolebrutinib is Not Superior to Teriflunomide in the Treatment of Relapsing Multiple Sclerosis

April 21, 2025
Next Post

Transcutaneous bilirubinometry linked to decreased serum testing and costs [Pediatrics Classics Series]

Worldwide smoking prevalence decreasing as number of smokers increases

Worldwide smoking prevalence decreasing as number of smokers increases

Adolescent smoking heavily influenced by parents and siblings

Varenicline and buproprion more effective than varenicline alone for tobacco abstinence

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher sleep apnea-specific hypoxic burden may predict postoperative cardiovascular complications and mortality in obstructive sleep apnea
  • Merck and Mayo Clinic launch AI-driven precision medicine lab
  • Lifestyle factors including higher body mass index and smoking are associated with changes in left-atrial size and function
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.